| 000 | 01333 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250512024222.0 | ||
| 264 | 0 | _c19890505 | |
| 008 | 198905s 0 0 eng d | ||
| 022 | _a0161-6412 | ||
| 024 | 7 |
_a10.1080/01616412.1988.11758591 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrooks, B R | |
| 245 | 0 | 0 |
_aThyrotropin releasing hormone uptake into serum and cerebrospinal fluid following intravenous or subcutaneous administration. _h[electronic resource] |
| 260 |
_bNeurological research _cDec 1988 |
||
| 300 |
_a236-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAmyotrophic Lateral Sclerosis _xdrug therapy |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aThyrotropin-Releasing Hormone _xadministration & dosage |
| 700 | 1 | _aKalin, N | |
| 700 | 1 | _aBeaulieu, D A | |
| 700 | 1 | _aBarksdale, C | |
| 700 | 1 | _aSufit, R L | |
| 700 | 1 | _aDills, D G | |
| 773 | 0 |
_tNeurological research _gvol. 10 _gno. 4 _gp. 236-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/01616412.1988.11758591 _zAvailable from publisher's website |
| 999 |
_c2912958 _d2912958 |
||